BC Centre for Excellence

Towards the Control of Chronic Diseases: Infectious and Socially Transmissible Diseases

Location: Academia Nacional de Medicina Av. Las Heras 3092 / Pacheco de Melo 3081 (CABA), C1425ASU Cdad. Autónoma de Buenos Aires, Argentina Cost: Free registration. Limited spots available. A round table to share strategies for preventive and assistive approaches to chronic, infectious, and socially contagious diseases. An exchange of experiences from Canada, the University of […]

Towards the Control of Chronic Diseases: Infectious and Socially Transmissible Diseases Read More »

International HIV Treatment as Prevention Workshop

International HIV Treatment as Prevention Workshop Political Segment What new targets for treatment? Which aim? Which resources? The International HIV Treatment as Prevention Workshop brings together academic, policy, industry, and community representatives to review and discuss research and policy progress in the field of HIV treatment as prevention. This Davos-style roundtable session will bring together

International HIV Treatment as Prevention Workshop Read More »

Double trouble: Treating pain and addiction

Our third “What’s New?” lecture will be Thursday December 12th between 12-12:55pm, featuring a presentation by Dr. Launette Rieb, of the St. Paul’s Addiction Medicine Fellowship Program, entitled “Double trouble: Treating pain and addiction”. Dr. Rieb will speak for approximately 40 minutes, allowing for about 15 minutes of questions and discussion. This lecture will take

Double trouble: Treating pain and addiction Read More »

HIV round

Presenter: Dr. Réjean Thomas Title: Updates on non-occupational PEP Dr. Thomas’ presentation is sponsored by Abbott Virology. About Dr. Thomas: Dr. Réjean Thomas is the Co-founder and President of the Clinique médicale l’Actuel, a clinic which specializes in the prevention, diagnosis, and treatment of HIV/AIDS, sexually transmitted infections, and hepatitis. Dr. Thomas is also a

HIV round Read More »

AIDS Care Round: A historical perspective of HIV in the DTES – and ongoing challenges

Please join us on Thursday, February 14, 2013 for an AIDS Care Round by Dr. Sue Burgess, titled ‘A historical perspective of HIV in the DTES – and ongoing challenges’. The AIDS Care Rounds are directed at health care professionals and treating and working with HIV-positive individuals. The BC-CfE also has videos from past AIDS

AIDS Care Round: A historical perspective of HIV in the DTES – and ongoing challenges Read More »

Novel Insights into HIV Resistance to Integrase Inhibitors

On Wednesday, February 13, the BC Centre for Excellence in HIV/AIDS Forefront Lecture Series will be presenting a lecture by Dr. Mark Wainberg titled “Novel Insights into HIV Resistance to Integrase Inhibitors”. Dr. Wainberg is Professor of Medicine and Microbiology and Immunology at McGill University and director of its AIDS Centre. Internationally recognized for his

Novel Insights into HIV Resistance to Integrase Inhibitors Read More »

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below